The National Aspergillosis Centre is part of the Manchester Fungal Infection Group (MFIG) who have just published an important paper in the very prestigious Nature Communications journal.
Sara Gago in Paul Bowyer’s lab has characterised a mutation carried by people that researchers have found make their airways stickier, thus enabling Aspergillus spores to stick and grow. The implications for infection (ABPA) are pretty clear and the group have already discovered that this mutation is common in people with ABPA (28% of patients in this study had this mutation). This leads us straight to thinking about screening out people who are prone to infection as they carry this gene mutation. We can then pay special attention to prevent them getting ABPA. What this means for people who already have ABPA is less clear, but certainly suggests another target for treatment.
Share this post
Latest News posts
Doctors need empathy
February 15, 2019
New Christmas Quiz Champion Crowned
February 15, 2019
National and European Centre of Excellence in Medical Mycology
February 15, 2019
COPD – getting the best out of treatments
February 15, 2019
EU debate on biosimilar drugs
February 15, 2019
Number of People in UK With Fungal Disease Rises
February 15, 2019
Medicine for the Mind
February 15, 2019
Assistance for Patients Who Cannot Afford Antifungal Drugs (US only)
February 15, 2019
How do I know that this research paper is any good?
February 15, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video